Pfizer Inc

Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA...

Kahn Swick & Foti, LLC ("KSF") (www.ksfcounsel.com), a nationally recognized Louisiana-based law firm with offices also in New York, and KSF partner Charles C. Foti, ...

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by David Simmons, President and General Manager, Established Produ...

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by David Simmons, President and General Manager, Established Produ...

As part of its commitment to improving the quality of patient care, Pfizer today announced that it will make available assessment scales used by physicians and others in...

Shionogi-ViiV Healthcare LLC today reported data from two Phase IIb studies showing that its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 (&apo...

Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phas...

Pfizer Inc. today announced, at the request of the U.S. Food and Drug Administration , the suspension of the chronic low back pain and painful diabetic peripheral neurop...